Uptake of Outpatient Monoclonal Antibody Treatments for COVID-19 in the United States: a Cross-Sectional Analysis.

Anderson, Timothy S; O'Donoghue, Ashley L; Dechen, Tenzin; Mechanic, Oren; Stevens, Jennifer P

Anderson, Timothy S; O'Donoghue, Ashley L; Dechen, Tenzin; Mechanic, Oren; Stevens, Jennifer P.

Afiliação

Anderson TS; Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. tsander1@bidmc.harvard.edu.
O'Donoghue AL; Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA. tsander1@bidmc.harvard.edu.
Dechen T; Harvard Medical School, Boston, MA, USA. tsander1@bidmc.harvard.edu.
Mechanic O; Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Stevens JP; Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA.

J Gen Intern Med ; 36(12): 3922-3924, 2021 12.

Article em En | MEDLINE | ID: mdl-34495464

Assuntos

COVID-19; Anticorpos Monoclonais; Estudos Transversais; Humanos; Pacientes Ambulatoriais; SARS-CoV-2; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google